ARCHIVES

It is The First FDA Withdrawl Of An Accelerated Approval

This article is from The Cancer Letter archive.

Vol. 37 No. Nov 18 special report | November 18, 2011

Download PDF Visit The Full Archive

Related Articles

FDA News: FDA Taking Comments on “First Generic” ANDA Process

November 21, 2014

Emphasis On Early Disease In Clinical Trials, Early Lung Cancer Detection Seen As “Landmark”

September 19, 1975

Nobel Laureate Baruch Blumberg Dies at 85

April 8, 2011

FDA Proposal On Dissemination of Off-Label Drug Information Doesn’t Go Far Enough, Cancer Groups Say

January 26, 1996

FDA Approves Gleevec For First Line Rx Of CML

January 31, 2003

Cancer Meetings Listed

March 26, 1993